Am I Eligible for Kidney Transplant? Complete India Guide with Free Checker Tool

Kidney transplant is the best treatment for end-stage kidney disease. It offers longer life expectancy, better quality of life, fewer dietary restrictions, and greater independence compared to any form of dialysis. Yet for thousands of patients across India, the question remains unanswered: "Am I eligible for a kidney transplant?" This guide provides a thorough, clinically accurate answer.

Written by Dr. Anil Prasad Bhatt, who has personally performed and managed over 1,500 kidney transplants including more than 100 ABO-incompatible transplants using advanced desensitization protocols, this guide covers every aspect of transplant eligibility in the Indian healthcare system.

Who Is Eligible for Kidney Transplant in India?

In broad terms, any patient with end-stage kidney disease (CKD Stage 5, eGFR below 15 mL/min) or those approaching it (CKD Stage 4 with eGFR below 20 mL/min) can be evaluated for kidney transplant. However, eligibility depends on multiple medical, legal, and logistical factors that we will examine in detail below.

Medical Eligibility Criteria

Transplant teams evaluate candidates across several domains:

1. Kidney function: eGFR below 20 mL/min, or on dialysis, or expected to need dialysis within 6-12 months. Pre-emptive transplant (before starting dialysis) is actually preferred when a living donor is available, as it offers the best outcomes.
2. Cardiovascular fitness: The heart must be strong enough to withstand transplant surgery, which is performed under general anaesthesia and typically lasts 3-4 hours. Patients undergo cardiac evaluation including echocardiography and sometimes angiography. Well-controlled heart disease is not an absolute contraindication.
3. Cancer screening: Patients must be cancer-free, typically for at least 2 years (varies by cancer type). Some low-risk cancers with successful treatment may have shorter wait times. Immunosuppression after transplant could reactivate dormant cancers, so thorough screening is essential.
4. Active infections: Active tuberculosis, HIV (in most Indian centres), hepatitis with active viral replication, and other active infections must be controlled before transplant. Hepatitis B and C carriers with suppressed viral loads can receive transplants in specialized centres.
5. BMI considerations: While there is no absolute BMI cutoff, obesity (BMI above 35) increases surgical risk. Most centres in India prefer BMI below 30-35. Patients may be asked to lose weight before being listed.
6. Age: There is no strict upper age limit. Patients in their 70s have received successful transplants. The evaluation focuses on biological fitness rather than chronological age. Very young children (below 5 kg body weight) present technical challenges but specialized paediatric transplant centres handle these cases.
7. Substance use: Active substance abuse (alcohol, drugs, tobacco) is typically a contraindication. Patients must demonstrate at least 6 months of abstinence with documented rehabilitation before being considered.
8. Mental health and compliance: Transplant recipients must take immunosuppressive medications lifelong without missing doses. Patients must demonstrate the ability and willingness to adhere to this regimen. Mental health conditions are not contraindications per se, but must be well-managed.

Conditions That Do NOT Prevent Transplant

Many patients incorrectly believe they cannot receive a transplant due to:

• Diabetes: Diabetic patients are excellent transplant candidates. In fact, transplant is superior to dialysis for diabetic patients in terms of survival. Some patients may even benefit from combined kidney-pancreas transplant.
• Age above 60: As mentioned, biological fitness matters more than age. Dr. Bhatt has successfully managed transplants in patients aged 65 and above.
• Previous transplant failure: Patients whose first transplant failed can receive a second or even third transplant. The evaluation is more complex due to sensitization (development of antibodies), but it remains possible.
• Incompatible blood groups: ABO-incompatible transplant is now a well-established procedure in India. Dr. Bhatt has performed over 100 such transplants using Daratumumab-based desensitization protocols with excellent outcomes.

Understanding Blood Group Compatibility

Blood group matching is one of the first factors evaluated in transplant planning. Here is how it works:

Important note on ABO-incompatible transplant: Thanks to modern desensitization protocols, blood group is no longer an absolute barrier to transplant. Centres of excellence, including those where Dr. Bhatt operates, routinely perform ABO-incompatible transplants with outcomes nearly equivalent to ABO-compatible ones. This has been transformational for patients with blood group O, who previously faced very limited donor options.

NOTTO Guidelines: Legal Framework for Transplant in India

The Transplantation of Human Organs and Tissues Act (THOTA) and the National Organ and Tissue Transplant Organisation (NOTTO) govern all organ transplants in India. Understanding these regulations is critical for patients planning a transplant:

Living Donor Transplant (Most Common in India)

Approximately 85% of kidney transplants in India use living donors. NOTTO allows donation from:

• Near relatives: Spouse, parents, siblings, children, grandparents, grandchildren. This category has a streamlined approval process through the hospital's transplant authorization committee.
• Other relatives or emotionally related donors: Uncles, aunts, cousins, in-laws, close friends with demonstrated emotional attachment. These require additional approval from the State Authorization Committee, which involves documentation of the relationship, affidavits, and sometimes interviews to rule out organ trafficking.
• Swap/paired donation: If your willing donor is incompatible with you but compatible with another patient (and vice versa), paired kidney exchange allows both transplants to proceed. Some centres in India facilitate this.

Living Donor Requirements

• Age: 18-65 years (can be extended to 70 in excellent health)
• Both kidneys must be normal on imaging
• No diabetes, uncontrolled hypertension, or active kidney disease
• BMI ideally below 30-32
• No active infections or cancer
• No coercion — donation must be entirely voluntary
• Adequate kidney function (eGFR typically above 80 mL/min)

Cadaver (Deceased Donor) Transplant

Cadaver transplant uses kidneys from brain-dead donors. In India, the cadaver donation rate is still very low (approximately 0.5 per million population, compared to 30-40 in Spain). Patients are placed on a waiting list managed by NOTTO or the regional organ sharing network (ROTTO/SOTTO/ZTCC).

Wait times vary significantly by region: 2-5 years in Delhi NCR and Mumbai, potentially longer in other states. Blood group O patients face the longest wait times due to the universal donor rule (O kidneys go to O patients first).

Transplant Cost Breakdown by City

Ongoing costs after the first year: Immunosuppressive medications cost approximately ₹8,000-15,000 per month. Regular blood tests (monthly initially, then quarterly) cost ₹2,000-4,000 per visit. Nephrologist consultations every 1-3 months.

The Transplant Evaluation Process: Step by Step

Once you and your nephrologist decide to pursue transplant, here is what the evaluation process looks like in India:

1. Nephrologist referral to transplant team — Your nephrologist writes a referral to the transplant centre. If you do not have a nephrologist, you can directly approach a transplant hospital.
2. Recipient evaluation (2-4 weeks): Comprehensive blood work, cardiac evaluation (echo, stress test, sometimes angiography), pulmonary function tests, cancer screening (PAP smear, mammography, PSA as appropriate), dental clearance, psychiatric evaluation, and social worker interview.
3. Donor evaluation (2-4 weeks, parallel): Similar comprehensive workup for the donor, including detailed kidney imaging (CT angiogram) to assess kidney anatomy, split function study, and extensive blood work.
4. Crossmatch testing: The donor's cells are tested against the recipient's blood to check for pre-formed antibodies. A positive crossmatch means higher rejection risk and may require desensitization.
5. HLA typing: Both donor and recipient are tissue-typed. Better HLA matching correlates with better long-term graft survival, though it is not an absolute requirement.
6. Authorization committee approval: For near relatives, the hospital committee reviews and approves. For unrelated donors, the case goes to the State Authorization Committee, which can take 4-8 weeks.
7. Surgery scheduling: Once all evaluations are complete and approvals obtained, surgery is scheduled, typically within 2-4 weeks.

Post-Transplant Care: The First Year and Beyond

A successful transplant is just the beginning. Long-term graft survival depends critically on post-transplant care:

• Immunosuppression: Lifelong medication to prevent rejection. Standard regimen in India includes tacrolimus, mycophenolate mofetil, and low-dose prednisolone. Missing even a few doses can trigger acute rejection.
• Monitoring schedule: Weekly blood tests for the first 3 months, then bi-weekly for 3 months, then monthly. Tests include tacrolimus levels, serum creatinine, complete blood count, and liver function.
• Infection prevention: Immunosuppression increases infection risk. Patients must take prophylactic medications for CMV, Pneumocystis, and tuberculosis. Avoiding crowds during respiratory illness seasons. Hand hygiene is critical.
• Diet after transplant: Dietary restrictions are significantly liberalized compared to dialysis. However, patients should avoid grapefruit (interacts with tacrolimus), maintain food hygiene to prevent infections, and manage weight gain (a common side effect of steroids).
• Cancer screening: Increased cancer surveillance due to immunosuppression. Annual skin exams, age-appropriate cancer screening, and monitoring for lymphoproliferative disorders.

Transplant vs Dialysis: Making the Decision

For patients who are eligible, transplant is almost always the better option. The numbers speak clearly: 5-year survival after transplant exceeds 85%, compared to approximately 50% for patients on dialysis. Quality of life is dramatically better. The ability to travel, work, eat normally, and live independently is largely restored after a successful transplant.

However, transplant is not available immediately for all patients. While waiting for a donor or completing evaluation, dialysis provides essential life support. The key is to not become complacent on dialysis and to actively pursue transplant evaluation throughout.

Frequently Asked Questions

Can I get a transplant if I have diabetes?

Yes. Diabetes is the most common cause of kidney failure in India, and diabetic patients are excellent transplant candidates. Transplant outcomes in well-managed diabetic patients are significantly better than remaining on dialysis.

Is there an age limit for kidney transplant?

There is no strict age limit. Evaluation focuses on overall health and fitness for surgery. Patients in their 70s have received successful transplants. Each case is assessed individually.

What if my family member wants to donate but we have different blood groups?

ABO-incompatible transplant is now a well-established, safe procedure performed at multiple centres across India. Specialized desensitization protocols reduce antibody levels before surgery, allowing successful transplant across blood group barriers.

How long will the transplanted kidney last?

Average graft survival from a living donor is 15-20 years. From a cadaver donor, 10-15 years. Many patients maintain functioning grafts for 25 years or more with good medication adherence and regular follow-up.

Does Ayushman Bharat cover kidney transplant?

Yes. Ayushman Bharat Pradhan Mantri Jan Arogya Yojana covers kidney transplant surgery at empanelled hospitals. Coverage varies by state and hospital tier but typically covers ₹2.5-5 lakh of the procedure cost.

Medical Disclaimer

This guide is for educational purposes and does not replace a transplant surgeon's or nephrologist's evaluation. Every patient's situation is unique, and transplant eligibility must be determined through proper medical workup. Consult your nephrologist for personalized advice.